[1] FUKUSHIGE S,HORII A.DNA methylation in cancer: A gene silencing mechanism and the clinical potential of its biomarkers.Tohoku J Exp Med,2013,229(3):173-185.

[2] PARPART S,WANG X W.MicroRNA regulation and its consequences in cancer.Curr Pathobiol Rep,2013,1(1):71-79.

[3] CROW M,DENK F,MCMAHON S B.Genes and epigenetic processes as prospective pain targets.Genome Med.2013,5(2):12.

[4] JAMES L I,FRYE S V.Targeting chromatin readers.Clin Pharmacol Ther,2013,93(4):312-314.

[5] SCHNEIDER E,CLARK D S.Cytochrome P450 (CYP) enzymes and the development of CYP biosensors.Biosens Bioelectron.2013,39(1):1-13.

[6] ZANGER U M,SCHWAB M.Cytochrome P450 enzymes in drug metabolism: Regulation of gene expression,enzyme activities,and impact of genetic variation.Pharmacol Ther, 2013,16: 103-141.

[7] MEECH R,MINERS J O,LEWIS B C,et al.The glycosidation of xenobiotics and endogenous compounds: Versatility and redundancy in the UDP glycosyltransferase superfamily.Pharmacol Ther,2012,134(2):200-218.

[8] BARBIER O,BLANGER A.Inactivation of androgens by UDP-glucuronosyltransferases in the human prostate.Best Pract Res Clin Endocrinol Metab,2008,22(2):259-270.

[9] MORRIS M,LIU D,WEAVER L M,et al.A structural basis for cellular uptake of GST-Fold proteins.PLos One,2011,6(3):17864.

DIDOVYK A,VERDINE G L.Structural origins of DNA target selection and nucleobase extrusion by a DNA cytosine methyltransferase.J Biol Chem,2012,287(48):40099-40105.

XIE S,CHEN Y,CHEN S,et al.Structure-metabolism relationships for the glucuronidation of flavonoids by UGT1A3 and UGT1A9.J Pharm Pharmacol,2011,63(2):297-304.

BABA Y,WATANABE M,BABA H.A review of the alterations in DNA methylation in esophageal squamous cell carcinoma.Surg Today,2013,5:doi.10.1007S00595-012-0451-4.

VASANTHAKUMAR A,LEPORE J B,ZEGAREK M H,et al.Dnmt3b is a haploinsufficient tumor suppressor gene in Myc-induced lymphomagenesis.Blood, 2013,121(11):2059-2063.

HABANO W,GAMO T,SUGAI T,et al.CYP1B1,but not CYP1A1,is downregulated by promoter methylation in colorectal cancers.Int J Oncol,2009,34(4):1085-1091.

JOANNA F,VAN GRUNSVEN L A,MATHIEU V,et al.Histone deacetylase inhibition and the regulation of cell growth with particular reference to liver pathobiology.J Cell Mol Med,2009,13(9B):2990-3005.

PHAM T X,L J.Dietary regulation of histone acetylases and deacetylases for the prevention of metabolic diseases.Nutrients,2012,28;4(12):1868-1886.

LEE S H,KIM I J,KIM J G,et al.Regulation of intestinal stem cell proliferation by human methyl-CpG-binding protein-2 in Drosophila.Cell Struct Funct,2011,36(2):197-208.

TANG Y,URS S,LIAW L.Hairy-related transcription factors inhibit Notch-induced smooth muscle alpha-actin expression by interfering with Notch intracellular domain/CBF-1 complex interaction with the CBF-1-binding site.Circ Res,2008,102(6):661-668.

HREBACKOVA J,HRABETA J,ECKSCHLAGER T.Valproic acid in the complex therapy of malignant tumors.Curr Drug Targets,2010,11(3):361-379.

WU Y,SHI X,LIU Y,et al.Histone deacetylase 1 is required for carbamazepine-induced CYP3A4 expression.J Pharm Biomed Anal,2012,58:78-82.

TIGGES J,WEIGHARDT H,WOLFF S,et al.Aryl hydrocarbon receptor repressor (AhRR) function revisited: repression of CYP1 activity in human skin fibroblasts is not related to AhRR expression.J Invest Dermatol,2013,133(1):87-96

DE LIMA J C,LOSS-MORAIS G,MARGIS R.MicroRNAs play critical roles during plant development and in response to abiotic stresses.Genet Mol Biol, 2012,35(4 suppl):1069-1077.

RANJHA R,PAUL J.Micro-RNAs in inflammatory diseases and as a link between inflammation and cancer.Inflamm Res,2013,62(4):343-355.

CARROLL A P,TOONEY P A,CAIRNS M J.Context-specific microRNA function in developmental complexity.J Mol Cell Biol,2013,5(2):73-84.

VELU V K,RAMESH R,SRINIVASAN A R.Circulating microRNAs as biomarkers in health and disease.J Clin Diagn Res,2012,6(10):1791-1795.

AMERES S L,HORWICH M D,HUNG J H,et al.Target RNA-directed trimming and tailing of small silencing RNAs.Science,2010,328(5985):1534-1539.

KALSCHEUER S,ZHANG X,ZENG Y,et al.Differential expression of microRNAs in early-stage neoplastic transformation in the lungs of F344 rats chronically treated with the tobacco carcinogen 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone.Carcinogenesis,2008,29(12):2394-2399.

WANG Y,HU H H,PANG H,et al.Lentiviral transgenic microRNA-based shRNA suppressed mouse cytochromosome P450 3A (CYP3A) expression in a dose-dependent and inheritable manner.PLoS One,2012,7(1):30560.

HUANG F F,CHAI C L,ZHANG Z,et al.The UDP-glucosyltransferase multigene family in Bombyx mori.BMC Genomics.November,2008,9:563.

BOCK K W,BOCK-HENNIG B S.UDP-glucuronosyltransferases (UGTs): From purification of Ah-receptor-inducible UGT1A6 to coordinate regulation of subsets of CYPs,UGTs,and ABC transporters by nuclear receptors.Drug Metab Rev,2010,42(1):6-13.

BOCK KW,KHLE C.Topological aspects of oligomeric UDP-glucuronosyltransferases in endoplasmic reticulum membranes: advances and open questions.Biochem Pharmacol,2009,77(9):1458-1465.

BAJRO M H,JOSIFOVSKI T,PANOVSKI M,et al.Promoter length polymorphism in UGT1A1 and the risk of sporadic colorectal cancer.Cancer Genet,2012,205(4):163-167.

FUJITA K,ANDO Y,YAMAMOTO W,et al.Association of UGT2B7 and ABCB1 genotypes with morphine-induced adverse drug reactions in Japanese patients with cancer.Cancer Chemother Pharmacol,2010,65(2):251-258.

GAGNON J F,BERNARD O,VILLENEUVE L,et al.Irinotecan inactivation is modulated by epigenetic silencing of UGT1A1 in colon cancer.Clin Cancer Res,2006,12(6):1850-1858.

ODA S,FUKAMI T,YOKOI T,et al.Epigenetic regulation is a crucial factor in the repression of UGT1A1 expression in the human kidney.Drug Metab Dispos,2013,11.doi:10.1124/dmd.113051201.

BIN Q,LUO J.Role of polymorphisms of GSTM1,GSTT1 and GSTP1 Ile105Val in hodgkin and non-hodgkin iymphoma risk: A human genome epidemiology (HuGE) review.Leuk Lymphoma,2013,54(1):14-20.

KATOH T,YAMANO Y,TSUJI M,et al.Genetic polymorphisms of human cytosol glutathione S-transferases and prostate cancer.Pharmacogenomics,2008,9(1):93-104.

SAXENA A,DHILLON V S,SHAHID M,et al.GSTP1 methylation and polymorphism increase the risk of breast cancer and the effects of diet and lifestyle in breast cancer patients.Exp Ther Med,2012,4(6):1097-1103.

TANG S C,WU M F,WONG R H,et al.Epigenetic mechanisms for silencing glutathione S-transferase m2 expression by hypermethylated specificity protein 1 binding in lung cancer.Cancer,2011,117(14):3209-3221.

MAVIS C K,SHANNON R,MOREY K,et al.Expression leveland DNAMethylation status of glutathione-S-transferase genes in normal murine prostate and TRAMP tumors.Prostate, 2009,69(12):1312-1324.